Hsp70 promotes maturation of uromodulin mutants that cause familial juvenile hyperuricemic nephropathy and suppresses cellular damage
Hsp70 promotes maturation of uromodulin mutants that cause familial juvenile hyperuricemic nephropathy and suppresses cellular damage
复制标题
Hsp70促进导致家族性青少年高尿酸血症肾病的尿调节蛋白突变体的成熟并抑制细胞损伤
DOI:
10.1007/s10157-022-02196-y
复制
发表时间:
2022
影响因子:
2.3
通讯作者:
Hisatome Ichiro
中科院分区:
文献类型:
--
作者:
Utami Sulistiyati Bayu;Endo Ryo;Hamada Toshihiro;Notsu Tomomi;Minato Hiroyuki;Komatsu Koji;Nakayama Yuji;Shirayoshi Yasuaki;Yamamoto Kazuhiro;Okada Shinichi;Ninomiya Haruaki;Otuki Akihiro;Hisatome Ichiro
BackgroundFamilial juvenile hyperuricemic nephropathy (FJHN) is an autosomal dominant disorder caused by mutations inUMOD. Here we studied effects of genetic expression and pharmacological induction of Hsp70 on theUMODmutants C112Y and C217G.MethodsWe expressed wild type (WT), C112Y and C217G in HEK293 cells and studied their maturation and cellular damage using western blot and flow cytometry.ResultsExpression of C112Y or C217G increased pro-apoptotic proteins, decreased anti-apoptotic proteins, and induced cellular apoptosis as examined by annexin V staining and flow cytometry. Overexpression of Hsp70 or administration of an Hsp70 inducer geranylgeranylacetone (GGA) promoted maturation of the mutant proteins, increased their secreted forms, normalized the levels of pro- and anti-apoptotic proteins and suppressed apoptosis.ConclusionThese findings indicated that Hsp70 enhanced maturation of C112Y and C217G and reduced cellular apoptosis, suggesting that Hsp70 induction might be of a therapeutic value for treatment of FJHN.